Generic Drug Sponsors May Discuss Alternative BE Approaches During Pre-ANDA Meetings

alternative approach
Final guidance removes a requirement that a PSG meeting be requested within 60 days of a revised PSG's publication. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics